Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aspergillopepsin-2 (EC 3.4.23.19), also known as aspergillopepsin II or Aspergillus niger acid proteinase B, is an extracellular aspartic endopeptidase produced by the fungus Aspergillus niger [1, 2]. It is a member of the A4 family of proteases, which is distinct from the pepsin-like A1 family; notably, it is insensitive to the common aspartic protease inhibitor pepstatin [2, 3]. The enzyme is a heterodimer consisting of a light chain and a heavy chain and exhibits optimal activity at highly acidic pH (1.5–3.0), making it functional in the gastric environment [1, 3]. Its biological role involves the non-specific degradation of proteins, and it has been shown to cleave specific bonds in substrates such as the B chain of insulin and ACTH [1, 3]. In the pharmaceutical and nutraceutical industries, aspergillopepsin-2 is utilized in digestive enzyme formulations (e.g., Proctase) to assist in the breakdown of dietary proteins, thereby addressing symptoms of indigestion or malabsorption [4].
Aspergillopepsin-2 acts as a proteolytic enzyme that hydrolyzes peptide bonds in dietary proteins under acidic conditions. In therapeutic applications, it serves as a digestive aid to compensate for endogenous enzyme deficiencies or to enhance protein digestion in the stomach.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aspergillopepsin-2.